Question

Q25. What intervention is essential prior to starting a client on atorvastatin therapy? A. Assessing for muscle strength B. Assessing the client's dietary intake C. Determining if the client is on digoxin therapy D. Monitoring liver function tests Q26. Which of the following is the antidote for Reteplase? A. Vitamin K B. Aminocaproic acid C. Vitamin B12 D. Protamine sulfate Q27. A 65-year-old client is brought to the emergency department complaining of a severe pressure chest pain. EKG show ST-segment elevation, and myocardial infarction is diagnosed. Tissue plasminogen activator is ordered. Which action is a priority nursing intervention? A. Monitor for kidney failure B. Monitor psychological status C. Monitor for signs of bleeding Q28. A client has a prescription for metoclopramide. For which condition should the nurse administer this medication to the postoperative client? D. Have heparin sodium available A. Urinary retention B. Incisional pain C. Paralytic ileus D. Deep vein thrombosis Q29. A 49-year-old client with a history of chronic pancreatitis has been prescribed Pancreatin. The nurse evaluates that the medication is having the optimal intended benefit if which effect is observed? A. Relief of heart burn B. Weight loss C. Reduction of fatty stool

Answer 1

25. Liver function tests to be done prior to the atorvastatin therapy intervention as the medication is metabolised by the hepatic enzyme. Option D is the correct answer.

26. Aminocaproic acid is the antidote for reteplase in case of toxicity. Option B is the correct answer.

27. The tissue plasminogen activator is a thrombolytic agent administered in patients with myocardial infarction to break down the blood clots. In elderly patients, the serious complication for this drug is intracranial haemorrhage. The nurse should monitor the signs of bleeding. Option C is the correct answer.

28. The medication metoclopramide is used to treat postoperative ileus also called paralytic ileus. Option C is the correct answer.

29. Reduction of fatty stool is an optimal intended benefit by pancreatin medication. Option C is the correct answer.